Sign In

CPG Infobase: Clinical Practice Guidelines


The CPG Infobase is a database of evidence-based Canadian clinical practice guidelines (CPGs). Maintained by Joule™, a CMA company, it includes approximately 1,200 CPGs developed or endorsed by authoritative medical or health organizations in Canada.

List of Guidelines

For Subject: Biological Markers
Number of CPGs:  12

  • Results 1-10
1.
2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure

View HTML
2017-Nov
Canadian Cardiovascular Society

Detailed Result

2.
The 2014 Canadian Cardiovascular Society heart failure management guidelines focus update: anemia, biomarkers, and recent therapeutic trial implications

View PDF
2015-Jan
Canadian Cardiovascular Society

Detailed Result

3.
Osteoporosis in menopause

View HTML
2014-Sept
Society of Obstetricians and Gynaecologists of Canada

Detailed Result

4.
Ostéoporose pendant la ménopause

View PDF
2014-sept
Société des obstétriciens et gynécologues du Canada

Detailed Result

5.
Fourth Canadian Consensus Conference on the diagnosis and treatment of dementia: recommendations for family physicians

View PDF
2014-May
Canadian Consensus Conference on the Diagnosis and Treatment of Dementia

Detailed Result

6.
Quatrième conférence consensuelle sur le diagnostic et le traitement de la démence: Recommandations pour les médecins de famille

View PDF
2014-mai
Canadian Consensus Conference on the Diagnosis and Treatment of Dementia

Detailed Result

7.
Presentation, diagnosis, and medical management of heart failure in children: Canadian cardiovascular society guidelines

View PDF
2013-Dec
Canadian Cardiovascular Society

Detailed Result

8.
The prognostic value of the DNMT3A biomarker in cytogenetically normal patients with acute myeloid leukemia

View PDF
2013-Nov
Cancer Care Ontario's Program in Evidence-based Care

Detailed Result Guideline Summary 

9.
Recommendations for the use of Troponin assays for rapid diagnosis of acute coronary syndrome in the emergency department

View PDF
2013-Mar
Canadian Agency for Drugs and Technologies in Health

Detailed Result

10.
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult

View PDF
2013-Feb
Canadian Cardiovascular Society

Detailed Result



Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.